Results 181 to 190 of about 10,092 (236)

Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research. [PDF]

J Clin Invest
Poppelaars F, Holers VM, Thurman JM.
europepmc   +1 more source

Targeted Complement Treatments in Glomerulopathies: A Comprehensive Review. [PDF]

J Clin Med
Gentile M, Manenti L.
europepmc   +1 more source

Current Understanding of the Pathogenesis of ANCA-Associated Vasculitis and Novel Treatment Options Targeting Complement Activation. [PDF]

Life (Basel)
Drouzas K, Kalogeropoulos P, Liapis G, Lionaki S.   +3 more
europepmc   +1 more source

Kidney transplant in patients with C3 glomerulopathy. [PDF]

Clin Kidney J
Attieh RM, Bharati J, Sharma P, Nair G, Ayehu G, Jhaveri KD.   +5 more
europepmc   +1 more source

Properdin-Mediated C5a Production Enhances Stable Binding of Platelets to Granulocytes in Human Whole Blood

, 2016
Adam Z. Blatt, Gurpanna Saggu, Koustubh V Kulkarni, Claudio Cortés, Joshua M. Thurman, Daniel Ricklin, John D. Lambris, Jesús G. Valenzuela, Viviana P. Ferreira   +8 more
openalex   +1 more source

Widely used commercial ELISA does not detect preHP-2, but recognizes properdin as a potential second member of the zonulin family

, 2017
Lucas Scheffler, Alyce Crane, Henrike Heyne, Anke Tönjes, Dorit Schleinitz, Christian Ihling, Michael Stümvoll, Rachel Freire, Maria Fiorentino, Alessio Fasano, Péter Kovács, John T. Heiker   +11 more
openalex   +1 more source

Tubulointerstitial injury in proteinuric chronic kidney diseases. [PDF]

Front Med (Lausanne)
Cortinovis M, Perico N, Remuzzi G.
europepmc   +1 more source

The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis. [PDF]

Arthritis Res Ther
Hernández-Díaz M, Rodríguez-González D, Heras-Recuero E, Gómez-Bernal F, Quevedo-Abeledo JC, González-Rivero AF, González-López E, Ocejo-Vinyals JG, Jimenez-Sosa A, González-Gay MÁ, Ferraz-Amaro I.   +10 more
europepmc   +1 more source

Corrigendum: Genetic investigation of Nordic patients with complement-mediated kidney diseases. [PDF]

Front Immunol
Rydberg V, Aradottir SS, Kristoffersson AC, Svitacheva N, Karpman D.   +4 more
europepmc   +1 more source